Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
147 hedge funds and large institutions have $806M invested in Dynavax Technologies in 2015 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 67 increasing their positions, 31 reducing their positions, and 11 closing their positions.
392% more call options, than puts
Call options by funds: $21.7M | Put options by funds: $4.41M
255% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 11
116% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 31
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
29% more capital invested
Capital invested by funds: $625M → $806M (+$181M)
23% more funds holding
Funds holding: 120 → 147 (+27)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$70M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$28.6M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$20.5M |
| 4 |
Jennison Associates
New York
|
+$17.3M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$10.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$17.9M |
| 2 |
AC
Amici Capital
New York
|
-$16.7M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$15.7M |
| 4 |
SCM
SAB Capital Management
New York
|
-$14.5M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$12M |
DVAX Hedge Fund Activity: Q3 2015 in Review
147 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2015, worth a combined $806M — up 29% from $625M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new DVAX positions and 11 closed out — a net gain of 28 holders — while 67 added to existing stakes and 31 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $70M. The largest seller was RA Capital Management, exiting entirely with an estimated $17.9M sold.
- 147 institutional investors held Dynavax Technologies (DVAX) as of Q3 2015, up from 120 in Q2 2015.
- Funds reported $806M of Dynavax Technologies stock for Q3 2015, up 29% quarter-over-quarter.
- 39 funds opened new Dynavax Technologies positions in Q3 2015 and 11 closed out, a net change of +28 holders.
- The largest Dynavax Technologies buyer in Q3 2015 was OrbiMed, an estimated $70M added.
- The largest Dynavax Technologies seller in Q3 2015 was RA Capital Management, an estimated $17.9M sold.
Based on aggregated 13F filings for Q3 2015.